Medical Technology Analyst Taylor discusses LivaNova (LIVN) RECOVER data recap with Interventional Psychiatrist, Dr. Gregg Friedman, on an Analyst/Industry conference call to be held on June 17 at 11 am.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIVN:
- LivaNova’s Annual Meeting Strengthens Shareholder Alignment
- LivaNova: patient cohort preliminary results of Recover study did not meet PE
- LivaNova price target raised to $80 from $75 at Mizuho
- LivaNova price target raised to $66 from $58 at Baird
- LivaNova price target raised to $90 from $82 at Jefferies